Versea Ophthalmics

We caught up with Rob Sambursky, MD at #ASCRS2025 and let’s just say… big things are happening at Verséa Ophthalmics 👀 Their #Biovance product franchise is revolutionizing #ocularsurfacedisease management and ocular surgery. It’s not your “conventional amniotic membrane”; Biovance® is decellularized, bidirectional, ringless, and packed with growth factors to help patients feel better quickly and completely. No chorion, no donor debris, just results. And let’s not forget, the opportunity to perform glueless, sutureless pterygium surgery. More innovation. Better outcomes. And more to come from the #VerseaOphthalmics team.